Limitations of the barcelona clinic liver cancer staging system with a focus on transarterial chemoembolization as a key modality for treatment of hepatocellular carcinoma
- PMID: 31041024
- PMCID: PMC6490251
- DOI: 10.1002/cld.530
Limitations of the barcelona clinic liver cancer staging system with a focus on transarterial chemoembolization as a key modality for treatment of hepatocellular carcinoma
Figures
References
-
- El‐Serag HB. Epidemiology of hepatocellular carcinoma in USA. Hepatol Res 2007;37(suppl 2):S88‐S94. - PubMed
-
- Marrero JA, Fontana RJ, Barrat A, Askari F, Conjeevaram HS, Su GL, et al. Prognosis of hepatocellular carcinoma: comparison of 7 staging systems in an American cohort. Hepatology 2005;41:707‐716. - PubMed
-
- Cillo U, Vitale A, Grigoletto F, Farinati F, Brolese A, Zanus G, et al. Prospective validation of the Barcelona Clinic Liver Cancer staging system. J Hepatol 2006;44:723‐731. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
